Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Pancreatic Neoplasms × Hydroxychloroquine × Clear all

Phase

Status

Sponsor Class

OTHER 9 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Respiratory Distress Syndrome 1 Pneumonia, Viral 1 Pancreatic Neoplasms 1 Glioma 1 Cytokine Release Syndrome 1

Interventions

Gemcitabine 15 Fluorouracil 8 Capecitabine 6 Leucovorin 5 Radiotherapy 4 Irinotecan 4 Cisplatin 4 Albumin-Bound Paclitaxel 4 130-nm albumin-bound paclitaxel 4 Taxes 3 Radiotherapy, Conformal 3 Docetaxel 3 irinotecan sucrosofate 2 dehydroftorafur 2 Specimen Handling 2 Radiosurgery 2 Pancreaticoduodenectomy 2 Cetuximab 2 trametinib 1 saracatinib 1 pegfilgrastim 1 lanreotide 1 ganitumab 1 durvalumab 1 conatumumab 1 beta-D-glucosylisophosphoramide mustard 1 Watchful Waiting 1 Surgical Procedures, Operative 1 Sodium Chloride 1 Saline Solution 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05518110 2024-09-26

PaTcH

Cancer Trials Ireland

Phase 2 Recruiting

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡